Literature DB >> 8564321

A prevalence study of age-associated memory impairment.

A Barker1, R Jones, C Jennison.   

Abstract

BACKGROUND: Age-associated memory impairment (AAMI) describes a non-disease ageing-related decline in memory. Pharmacological treatment trials have been reported and DSM-IV has introduced a term for the disorder. No prevalence study with the original criteria has previously been published.
METHOD: An age-stratified sample was taken of 50-95-year-olds registered with a local health centre. Diagnosis of AAMI was made by questionnaire, cognitive testing, and medical and psychiatric assessment.
RESULTS: Prevalence rates for the total population and for the over-50s were estimated to be 5.8% and 18.5%, respectively. These rates are dramatically affected by minor alterations to individual criteria.
CONCLUSIONS: It appears AAMI is less common than previous estimates suggested, although the diagnostic criteria do not satisfactorily define people with an age-related decline in memory. Complaint of memory decline is more strongly correlated with measures of affect and personality than with measures of current memory test performance or estimates of memory decline.

Entities:  

Mesh:

Year:  1995        PMID: 8564321     DOI: 10.1192/bjp.167.5.642

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  12 in total

Review 1.  Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease.

Authors:  Jennifer G Goldman; Neelum T Aggarwal; Cynthia D Schroeder
Journal:  Neurodegener Dis Manag       Date:  2015-10-30

Review 2.  Age-associated memory impairment. Normal aging or warning of dementia?

Authors:  T Hänninen; H Soininen
Journal:  Drugs Aging       Date:  1997-12       Impact factor: 3.923

3.  Quantitative MRI findings and cognitive impairment among community dwelling elderly subjects.

Authors:  H Koga; T Yuzuriha; H Yao; K Endo; S Hiejima; Y Takashima; F Sadanaga; T Matsumoto; A Uchino; K Ogomori; A Ichimiya; H Uchimura; N Tashiro
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

4.  Neuropsychological characteristics of mild cognitive impairment subgroups.

Authors:  O L Lopez; J T Becker; W J Jagust; A Fitzpatrick; M C Carlson; S T DeKosky; J Breitner; C G Lyketsos; B Jones; C Kawas; L H Kuller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08-15       Impact factor: 10.154

Review 5.  [Mild cognitive disorder. Questions of definition, diagnosis, prognosis and therapy].

Authors:  A Kurz; J Diehl; M Riemenschneider; R Perneczky; N Lautenschlager
Journal:  Nervenarzt       Date:  2004-01       Impact factor: 1.214

6.  Mild cognitive impairment risk factor survey of the Xinjiang Uyghur and Han elderly.

Authors:  Kabinuer Keyimu; Xiao-Hui Zhou; Hai-Jun Miao; Ting Zou
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 7.  The Calcium/Calmodulin-Dependent Kinases II and IV as Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders.

Authors:  Kinga Sałaciak; Aleksandra Koszałka; Elżbieta Żmudzka; Karolina Pytka
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

8.  Neuropsychiatric symptoms in mild cognitive impairment: An analysis and its impact on caregiving.

Authors:  Surbhi C Trivedi; Alka A Subramanyam; Charles Pinto; Dhananjay D Gambhire
Journal:  Indian J Psychiatry       Date:  2013-04       Impact factor: 1.759

Review 9.  The borderland between normal aging and dementia.

Authors:  Raymond Y Lo
Journal:  Ci Ji Yi Xue Za Zhi       Date:  2017 Apr-Jun

10.  Accuracy and Reliability of Subjective Answer about Age of Onset in Psoriasis.

Authors:  Jae-Wook Jeon; Hyuck-Hoon Kwon; Seong-Jin Jo; Ji-Young Ahn; Mi-Youn Park; Jai-Il Youn
Journal:  Ann Dermatol       Date:  2017-12-26       Impact factor: 1.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.